PFIZER INC. v. SANOFI PASTEUR INC. -
Before Lourie, Bryson, and Stark. Appeal from the Patent Trial and Appeal Board....more
4/10/2024
/ Appeals ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Life Sciences ,
Merck ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pfizer ,
Pharmaceutical Industry ,
Prior Art ,
Sanofi
MEDTRONIC, INC. v. TELEFLEX INNOVATIONS -
Before Moore, Lourie, and Dyk. Appeal from the Patent Trial and Appeal Board.
Summary: A close prima facie case of obviousness can be overcome by strong evidence of objective...more
Johnson & Johnson (“J&J”) announced on November 1, 2022, that it will acquire Abiomed for an upfront payment of $380.00 per share in cash, which equates to about $16.6 billion. The acquisition is expected to be completed in...more
MYLAN PHARMACEUTICALS INC. v. MERCK SHARP & DOHME CORP. -
Before Lourie, Reyna and Stoll. Appeal from the Patent Trial and Appeal Board. -
Summary: “At once envisage” what is missing cannot fill in the gap to establish...more
Baxter International Inc. (“Baxter”) has agreed to acquire Hillrom for $10.5 billion ($156 per share) in a deal expected to close in 2022. After assumption of debt, the total enterprise value of the deal is approximately...more
The FDA announced 510(k) clearance for Inari Medical’s FlowTriever device for the treatment of pulmonary embolism (“PE”). According to Inari, the FlowTriever system is the first thrombectomy device cleared for the treatment...more
Allergan recently announced that it has completed its acquisition of AqueSys. AqueSys is a privately held company, headquartered in Orange County, California, focusing on “commercializing implantable devices that will...more